Roy R, Kumar A
Cureus. 2025; 17(2):e78759.
PMID: 40070633
PMC: 11894770.
DOI: 10.7759/cureus.78759.
Chakrabarti B, McKnight E, Pearson M, Dowie L, Richards J, Choudhury-Iqbal M
NPJ Prim Care Respir Med. 2025; 35(1):12.
PMID: 40069195
PMC: 11897336.
DOI: 10.1038/s41533-025-00421-1.
Hellings P, Conti D, Bertels X, Backer V, Brusselle G, De Corso E
Front Allergy. 2025; 6:1540499.
PMID: 40065834
PMC: 11891202.
DOI: 10.3389/falgy.2025.1540499.
Khanna V, Singh K
Mol Cell Biochem. 2024; 480(3):1431-1448.
PMID: 39254870
DOI: 10.1007/s11010-024-05110-0.
Nagoya K, Tsujimura T, Yoshihara M, Watanabe M, Magara J, Kawasaki K
Front Physiol. 2024; 15:1445336.
PMID: 39170764
PMC: 11337103.
DOI: 10.3389/fphys.2024.1445336.
Efficacy and Safety of Acupuncture in Managing COPD: An Overview of Systematic Reviews.
Zeng Q, Liu L, Chen Y, Chen D, Zhou Z, Hu W
Int J Chron Obstruct Pulmon Dis. 2024; 19():1721-1739.
PMID: 39081776
PMC: 11288361.
DOI: 10.2147/COPD.S464546.
The Role of Exhaled Breath Condensate in Chronic Inflammatory and Neoplastic Diseases of the Respiratory Tract.
Kita K, Gawinowska M, Chelminska M, Niedoszytko M
Int J Mol Sci. 2024; 25(13).
PMID: 39000502
PMC: 11242091.
DOI: 10.3390/ijms25137395.
Predicting the risk of pulmonary infection in patients with chronic kidney failure: A-CGHS risk score-a retrospective study.
Deng W, Liu C, Cheng Q, Yang J, Chen W, Huang Y
Int Urol Nephrol. 2024; 56(7):2391-2402.
PMID: 38436825
DOI: 10.1007/s11255-024-03953-6.
Effect of chronic lung diseases on angina pectoris among Indian adults: longitudinal ageing study in India.
Ahmed W, Dixit P
Sci Rep. 2024; 14(1):2372.
PMID: 38287095
PMC: 10825144.
DOI: 10.1038/s41598-024-52786-x.
Post Hoc Analysis of Lung Function Improvement and Patient-Reported Outcomes With Revefenacin in Adults With Moderate-to-Very Severe COPD and Comorbid Anxiety or Depression.
Yohannes A, Iyer A, Clay C, Cochran L, Chen X, Lombardi D
Chronic Obstr Pulm Dis. 2024; 11(2):196-205.
PMID: 38241514
PMC: 11075345.
DOI: 10.15326/jcopdf.2023.0465.
Impact of comorbidities in COPD clinical control criteria. The CLAVE study.
Almagro P, Soler-Cataluna J, Huerta A, Gonzalez-Segura D, Cosio B
BMC Pulm Med. 2024; 24(1):6.
PMID: 38166965
PMC: 10759491.
DOI: 10.1186/s12890-023-02758-0.
Decline of the chronic respiratory disease mortality in the WHO Western Pacific Region.
Khaltaev N, Axelrod S
J Thorac Dis. 2023; 15(10):5801-5810.
PMID: 37969316
PMC: 10636449.
DOI: 10.21037/jtd-22-1466.
Association Between Oral Health and Airflow Limitation: Analysis Using a Nationwide Survey in Korea.
Kim S, Gu S, Kim J, Im Y, Cho J, Kim Y
J Korean Med Sci. 2023; 38(31):e241.
PMID: 37550809
PMC: 10412030.
DOI: 10.3346/jkms.2023.38.e241.
How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction?.
Celik A, Kilicaslan B, Temizhan A, Guvenc T, Altay H, Cavusoglu Y
Anatol J Cardiol. 2023; 27(6):308-318.
PMID: 37257015
PMC: 10250766.
DOI: 10.14744/AnatolJCardiol.2023.3297.
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists.
Agusti A, Bohm M, Celli B, Criner G, Garcia-Alvarez A, Martinez F
Clin Res Cardiol. 2023; 113(2):195-204.
PMID: 37233751
PMC: 10215047.
DOI: 10.1007/s00392-023-02217-0.
Serum levels of erythropoietin in patients with chronic obstructive pulmonary disease and anemia.
Rezvani A, Masoompour S, Azarpira N, Monjazeb R, Akbarzadeh M, Salimi M
Sci Rep. 2023; 13(1):6990.
PMID: 37117600
PMC: 10147932.
DOI: 10.1038/s41598-023-34290-w.
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.
Larney S, Jones N, Hickman M, Nielsen S, Ali R, Degenhardt L
Addiction. 2023; 118(8):1527-1539.
PMID: 36843415
PMC: 10330006.
DOI: 10.1111/add.16178.
The Diagnosis and Treatment of COPD and Its Comorbidities.
Kahnert K, Jorres R, Behr J, Welte T
Dtsch Arztebl Int. 2023; 120(25):434-444.
PMID: 36794439
PMC: 10478768.
DOI: 10.3238/arztebl.m2023.027.
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.
Kayongo A, Robertson N, Siddharthan T, Ntayi M, Ndawula J, Sande O
Front Immunol. 2023; 13:1085551.
PMID: 36741369
PMC: 9890194.
DOI: 10.3389/fimmu.2022.1085551.
Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier.
Kuang X, Wang Y, Liu S, Chang L, Yin Y, Li Z
Food Sci Nutr. 2023; 11(1):390-407.
PMID: 36655081
PMC: 9834855.
DOI: 10.1002/fsn3.3070.